Nov 01, 2022 / NTS GMT
Presentation
Nov 01, 2022 / NTS GMT
=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Pharma Co., Ltd. - CEO, President & Representative Director
* Toru Kimura
Sumitomo Pharma Co., Ltd. - EVP of Global Corporate Strategy, Regenerative & Cellular Medicine Off. and Representative Director
* Yoshiharu Ikeda
Sumitomo Pharma Co., Ltd. - Senior Exe. Officer of Cancer, Modality & Drug Research Div., Head of Japan Busi Unit and Director
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
=====================
Hiroshi Nomura - Sumitomo Pharma Co., Ltd. - CEO, President &
Sumitomo Pharma Co Ltd
(OTCPK:DNPUF)
$
8.4
(0%)
Market Cap: 3.52 Bil
Enterprise Value: 4.54 Bil
PE Ratio: 4.78
PB Ratio: 1.74
GF Score: 65/100 Q2 2023 Sumitomo Pharma Co Ltd Earnings Presentation Transcript
Nov 01, 2022 / NTS GMT
Release Date Price:
$6.89
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot